Kyntra Bio, Inc. (KYNB)
NASDAQ: KYNB · Real-Time Price · USD
5.28
+0.43 (8.87%)
At close: Oct 19, 2026, 4:00 PM EDT
5.28
0.00 (0.00%)
After-hours: Oct 19, 2026, 4:00 PM EDT
Kyntra Bio Market Cap
Kyntra Bio has a market cap or net worth of $21.38 million as of October 19, 2026. It is the 37,174th most valuable company in the world and the 5,225th biggest in the United States. Its market cap has decreased by 49.10% in one year.
Market Cap
21.38M
Enterprise Value
-69.94M
1-Year Change
-49.10%
Global Rank
Country Rank
#5,225 United States
Category
ChartMarket Cap Chart
Since November 14, 2014, Kyntra Bio's market cap has decreased from $1.22B to $21.38M, a decrease of -98.25%. That is a compound annual growth rate of -28.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 19, 2026 | 21.38M | -39.78% |
| Dec 31, 2025 | 35.50M | -33.52% |
| Dec 31, 2024 | 53.40M | -38.76% |
| Dec 29, 2023 | 87.20M | -94.21% |
| Dec 30, 2022 | 1.51B | 15.15% |
| Dec 31, 2021 | 1.31B | -61.28% |
| Dec 31, 2020 | 3.38B | -9.80% |
| Dec 31, 2019 | 3.74B | -4.85% |
| Dec 31, 2018 | 3.93B | 1.17% |
| Dec 29, 2017 | 3.89B | 187.60% |
| Dec 30, 2016 | 1.35B | -27.68% |
| Dec 31, 2015 | 1.87B | 22.78% |
| Dec 31, 2014 | 1.52B | 24.27% |
| Nov 14, 2014 | 1.22B | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Impact BioMedical | 22.90M |
| Context Therapeutics | 22.42M |
| Fractyl Health | 20.56M |
| Quantum BioPharma | 19.98M |
| Cocrystal Pharma | 19.65M |
| Quoin Pharmaceuticals | 18.74M |
| Estrella Immunopharma | 18.70M |
| Akari Therapeutics, | 18.69M |